Regulatory Affairs

Regulatory affairs in radiopharmaceuticals and pharmaceuticals ensure that medicinal products meet established standards of safety, efficacy and quality before reaching patients. These processes involve preparing and managing submissions to authorities such as the U.S. Food and Drug Administration and the European Medicines Agency, while ensuring compliance with international frameworks, including ICH guidelines. Radiopharmaceuticals present additional complexity due to their radioactive component, requiring coordination between medicinal regulators and radiation safety authorities, as well as detailed evaluation of dosimetry, biodistribution and manufacturing controls under Good Manufacturing Practice. Conventional pharmaceuticals follow structured pathways from preclinical research through phased clinical trials to marketing authorisation and post-marketing surveillance. Effective regulatory oversight safeguards public health while supporting innovation in advanced therapeutics and personalised medicine.

home » regulatory affairs